U.S. top court denies Teva stay in Copaxone patent fight

WASHINGTON, April 18 Fri Apr 18, 2014 4:03pm EDT

WASHINGTON, April 18 (Reuters) - U.S. Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd that would have prevented a lower court ruling from going into effect while the court considers an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone.

The decision could help pave the way for generic competitors to go on the market as soon as next month. (Reporting by Lawrence Hurley; Editing by Sandra Maler)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.